633 related articles for article (PubMed ID: 9390264)
1. Empirical free energy calculations of human immunodeficiency virus type 1 protease crystallographic complexes. II. Knowledge-based ligand-protein interaction potentials applied to thermodynamic analysis of hydrophobic mutations.
Verkhivker GM
Pac Symp Biocomput; 1996; ():638-52. PubMed ID: 9390264
[TBL] [Abstract][Full Text] [Related]
2. Empirical free energy calculations of ligand-protein crystallographic complexes. I. Knowledge-based ligand-protein interaction potentials applied to the prediction of human immunodeficiency virus 1 protease binding affinity.
Verkhivker G; Appelt K; Freer ST; Villafranca JE
Protein Eng; 1995 Jul; 8(7):677-91. PubMed ID: 8577696
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of resistance to HIV-1 protease inhibition: a plausible hypothesis.
Luque I; Todd MJ; Gómez J; Semo N; Freire E
Biochemistry; 1998 Apr; 37(17):5791-7. PubMed ID: 9558312
[TBL] [Abstract][Full Text] [Related]
4. Examining methods for calculations of binding free energies: LRA, LIE, PDLD-LRA, and PDLD/S-LRA calculations of ligands binding to an HIV protease.
Sham YY; Chu ZT; Tao H; Warshel A
Proteins; 2000 Jun; 39(4):393-407. PubMed ID: 10813821
[TBL] [Abstract][Full Text] [Related]
5. A structural and thermodynamic escape mechanism from a drug resistant mutation of the HIV-1 protease.
Vega S; Kang LW; Velazquez-Campoy A; Kiso Y; Amzel LM; Freire E
Proteins; 2004 May; 55(3):594-602. PubMed ID: 15103623
[TBL] [Abstract][Full Text] [Related]
6. Binding free energy contributions of interfacial waters in HIV-1 protease/inhibitor complexes.
Lu Y; Yang CY; Wang S
J Am Chem Soc; 2006 Sep; 128(36):11830-9. PubMed ID: 16953623
[TBL] [Abstract][Full Text] [Related]
7. Importance of polar solvation and configurational entropy for design of antiretroviral drugs targeting HIV-1 protease.
Kar P; Lipowsky R; Knecht V
J Phys Chem B; 2013 May; 117(19):5793-805. PubMed ID: 23614718
[TBL] [Abstract][Full Text] [Related]
8. Molecular dynamics study of the connection between flap closing and binding of fullerene-based inhibitors of the HIV-1 protease.
Zhu Z; Schuster DI; Tuckerman ME
Biochemistry; 2003 Feb; 42(5):1326-33. PubMed ID: 12564936
[TBL] [Abstract][Full Text] [Related]
9. Efficiency of a second-generation HIV-1 protease inhibitor studied by molecular dynamics and absolute binding free energy calculations.
Lepsík M; Kríz Z; Havlas Z
Proteins; 2004 Nov; 57(2):279-93. PubMed ID: 15340915
[TBL] [Abstract][Full Text] [Related]
10. Relation between sequence and structure of HIV-1 protease inhibitor complexes: a model system for the analysis of protein flexibility.
Zoete V; Michielin O; Karplus M
J Mol Biol; 2002 Jan; 315(1):21-52. PubMed ID: 11771964
[TBL] [Abstract][Full Text] [Related]
11. Structural role of the 30's loop in determining the ligand specificity of the human immunodeficiency virus protease.
Swairjo MA; Towler EM; Debouck C; Abdel-Meguid SS
Biochemistry; 1998 Aug; 37(31):10928-36. PubMed ID: 9692985
[TBL] [Abstract][Full Text] [Related]
12. Structural parameterization of the binding enthalpy of small ligands.
Luque I; Freire E
Proteins; 2002 Nov; 49(2):181-90. PubMed ID: 12210999
[TBL] [Abstract][Full Text] [Related]
13. Rapid and accurate prediction of binding free energies for saquinavir-bound HIV-1 proteases.
Stoica I; Sadiq SK; Coveney PV
J Am Chem Soc; 2008 Feb; 130(8):2639-48. PubMed ID: 18225901
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics and free energy studies on the wild-type and mutated HIV-1 protease complexed with four approved drugs: mechanism of binding and drug resistance.
Alcaro S; Artese A; Ceccherini-Silberstein F; Ortuso F; Perno CF; Sing T; Svicher V
J Chem Inf Model; 2009 Jul; 49(7):1751-61. PubMed ID: 19537723
[TBL] [Abstract][Full Text] [Related]
15. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
Krystek S; Stouch T; Novotny J
J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
[TBL] [Abstract][Full Text] [Related]
16. Thermodynamic mapping of the inhibitor site of the aspartic protease endothiapepsin.
Gómez J; Freire E
J Mol Biol; 1995 Sep; 252(3):337-50. PubMed ID: 7563055
[TBL] [Abstract][Full Text] [Related]
17. Computational titration analysis of a multiprotic HIV-1 protease-ligand complex.
Spyrakis F; Fornabaio M; Cozzini P; Mozzarelli A; Abraham DJ; Kellogg GE
J Am Chem Soc; 2004 Sep; 126(38):11764-5. PubMed ID: 15382890
[TBL] [Abstract][Full Text] [Related]
18. Absolute free energies of binding of peptide analogs to the HIV-1 protease from molecular dynamics simulations.
Bartels C; Widmer A; Ehrhardt C
J Comput Chem; 2005 Sep; 26(12):1294-305. PubMed ID: 15981257
[TBL] [Abstract][Full Text] [Related]
19. Prediction of the binding energy for small molecules, peptides and proteins.
Schapira M; Totrov M; Abagyan R
J Mol Recognit; 1999; 12(3):177-90. PubMed ID: 10398408
[TBL] [Abstract][Full Text] [Related]
20. Automated molecular simulation based binding affinity calculator for ligand-bound HIV-1 proteases.
Sadiq SK; Wright D; Watson SJ; Zasada SJ; Stoica I; Coveney PV
J Chem Inf Model; 2008 Sep; 48(9):1909-19. PubMed ID: 18710212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
